Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a small administrative update with no changes to study details.SummaryDifference0.0%

- Check18 days agoChange DetectedResults have been posted for the study and the status updated to Terminated; the page now reflects the published outcomes.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 on the page.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed; this appears to be an administrative update with no visible impact on the study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a glossary display, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision label v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and revision label v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows a minor revision update (Revision: v3.3.4) replacing the previous version v3.3.3 without affecting the core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.